v3.25.2
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
Preferred Stock
Series A Preferred Stock
Preferred Stock
Common Stock
Subscription Receivable
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Total
Beginning balance at Dec. 31, 2023 $ 420 $ 14,794 $ (4,276) $ 5,284,362 $ (11,359,183) $ (15,179) $ (6,079,062)
Beginning balance (in Shares) at Dec. 31, 2023 82,096 5,744,929          
Stock-Based Compensation - Restricted Stock Agreements 46,016 46,016
Net Loss (1,034,161) (1,034,161)
Ending balance at Mar. 31, 2024 $ 420 $ 14,794 (4,276) 5,330,378 (12,393,344) (15,179) (7,067,207)
Ending balance (in Shares) at Mar. 31, 2024 82,096 5,744,929          
Beginning balance at Dec. 31, 2024 $ 420 $ 14,554 (3,700) 6,195,322 (14,647,702) (15,179) (8,456,285)
Beginning balance (in Shares) at Dec. 31, 2024 82,096 7,033,330          
Stock-Based Compensation - Restricted Stock Agreements 42,500 42,500
Issuance of Common Stock
Issuance of Common Stock (in Shares) 56          
Offering Costs (1,427,079) (1,427,079)
Conversion of Preferred Stock to Common Stock $ (420) $ 420
Conversion of Preferred Stock to Common Stock (in Shares) (82,096) 82,096          
Conversion of Convertible Debt and Accrued Interest (Note 6) $ 191 6,611,214 6,611,405
Conversion of Convertible Debt and Accrued Interest (Note 6) (in Shares) 1,912,176          
Issuance of Common Stock in Connection with IPO and Over-allotment, Net of $1,176,800 of Offering Costs $ 169 5,608,031 5,608,200
Issuance of Common Stock in Connection with IPO and Over-allotment, Net of $1,176,800 of Offering Costs (in Shares) 1,696,250          
Underwriter Warrants 130,980 130,980
Issuance of Common Stock for Services 164,647 164,647
Net Loss (1,067,673) (1,067,673)
Ending balance at Mar. 31, 2025 $ 15,334 $ (3,700) $ 17,325,615 $ (15,715,375) $ (15,179) $ 1,606,695
Ending balance (in Shares) at Mar. 31, 2025 10,723,908